Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity
215 Citations•2024•
Patricia J. Rodriguez, Brianna M. Goodwin Cartwright, Samuel Gratzl
Although most adults with overweight or obesity experienced 5% or greater weight loss with treatment, the benefit was greater with tirzepatide.
Abstract
In this population of adults with overweight or obesity, use of tirzepatide was associated with significantly greater weight loss than semaglutide. Future study is needed to understand differences in other important outcomes.